Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancer

作者：Zhu, Rongying; Yang, Xiaodong; Xue, Xiang; Shen, Mingjing; Chen, Feng; Chen, Xiaodong; Tsai, Ying; Keng, Peter C.; Chen, Yongbing; Lee, Soo Ok^*; Chen, Yuhchyau

来源：Biochimica et Biophysica Acta-Molecular Cell Research, 2018, 1865(12): 1878-1890.

DOI：10.1016/j.bbamcr.2018.09.005

• NSCLC
• NED
• Radioresistance
• IL-6
• cAMP
• MEK/Erk

Radiation treatment induces neuroendocrine differentiation (NED) in non-small cell lung cancer (NSCLC) A549 and H157 cells, so higher NE-like features in radioresistant A549 (A549R26-1) and H157 (H157R24-1) cells are observed than in parental cells. We detected higher NED marker expressions in A549R26-1 cell-derived tumors than in A549 cell-derived tumors. In mechanism studies, we found that NED induction in A549R26-1 and H157R24-1 cells was accompanied by increased intracellular cAMP and IL-6 levels. Treatment of radioresistant lung cancer cells with the inhibitor (SQ22536) of adenylate cyclase (AC) which is the enzyme responsible for the cAMP production, or the neutralizing antibody (Ab) of IL-6, resulted in decreased NE-like features in radioresistant lung cancer cells. In addition, we found MEK/Erk is the signaling pathway that triggers the cAMP- and IL-6-mediated NED induction in radioresistant lung cancer cells. Also, we found that MEK/Erk signaling pathway inhibition decreased NED in radioresistant cells. Radioresistant lung cancer cells exhibiting high NE-like features also showed higher radioresistance and higher metastatic potential than parental cells. When we inhibited cAMP-, or IL-6-mediated pathways, or the downstream MEK/Erk signaling pathway, radiosensitivity of radioresistant lung cancer cells was significantly increased and their metastatic potential was significantly reduced. In in vivo mouse studies, reducing NED by treating mice with the MEK/Erk inhibitor increased radiosensitivity. Immunohistochemical staining of tumor tissues lowered expressions of the NED/epithelial-mesenchymal transition (EMT)/metastatic markers when mice were treated with the MEK/Erk inhibitor.

• 出版日期2018-12
• 单位苏州大学